Elis cleft lip and/or palate (CL/P), which results from genetic and environmental factors, is the most common human craniofacial birth defect (1 in 500-2500 live births). Genetically, CL/P frequently results from WNT, P63, and IRF6 mutations. However, how these genes interact to specify mammalian midfacial formation is unknown. We generated a novel mouse model of CL/P via compound loss of Pbx genes, which encode TALE homeodomain transcription factors, in the cephalic ectoderm. We found that Pbx genes regulate Wnt9b-Wnt3 by binding to a previously unknown midfacial regulatory enhancer. In turn, we discovered that Wnt canonical (WntCan) signaling is essential for midfacial ectodermspecific expression of p63 and its target gene Irf6, the mouse ortholog of IRF6, which is most commonly mutated in human CL/P. Intriguingly, p63 and Irf6 are mediators of apoptotic programs in various contexts. We established that dysregulation of a previously unknown, essential Pbx-dependent WntCan-p63-Irf6 regulatory module leads to localized suppression of apoptosis and CL/P. We demonstrated the primary role of Pbx-directed WntCan signaling as a key determinant of lip morphogenesis by complete rescue of the CL in Pbx mutants via ectopic expression of Wnt1 in cephalic ectoderm cells. Interestingly, while the elements regulating Wnt9b and Wnt3, p63, and Irf6 within the Pbxcontrolled module are conserved in mammals, their conservation is lost in other amniotes, Xenopous, stickleback and zebrafish. Thus, it is conceivable that the identified Pbx-directed regulatory module is an evolutionary innovation associated with the appearance of elaborate choanae, upper lip, and primary and secondary palate in mammals, all of which can be affected by CL/P. The Pbx-mediated regulatory module identified and characterized in this study, which is required for normal midfacial formation, delineates a novel network of candidate genes for diagnosis, prevention, and repair of human CL/P. Cleft palate, the most common craniofacial birth defect, arises due to the failure of adequate growth of the embryonic palatal shelves. During palatogenesis, palatal mesenchyme undergoes increased cell proliferation for palatal growth, elevation and fusion of the two palatal shelves. Interestingly, all three TGFβ isoforms (1, 2 and 3) are expressed in the palatal mesenchyme throughout these steps of palatogenesis. However, the role of TGFβ in promoting palatal mesenchymal cell proliferation has never been explored. The purpose of the study was to identify the effect of TGFβ on human embryonic palatal mesenchymal (HEPM) cell proliferation. Our results showed that all isoforms of TGFβ, especially TGFβ3, increased HEPM cell proliferation by up-regulating the expression of cyclins and Cyclin Dependent Kinases. Furthermore, TGFβ activated both its Smad dependent and Smad independent pathways to bind to the promoter to activate c-Myc gene. The role of TGFβ in palatal mesenchymal cell proliferation is essential for complete palatal confluency. We hope that our data will shed some light to the potential role of TGFβ as a therapeutic molecule to correct cleft palate by promoting growth. Data presented here are an example of Waddingtonian epigenetics. Our process of linking genetic and non-genetic clues that together produce a cleft palate started several years ago. Previously, we described that in the complete absence of the skeletal musculature mouse palatal shelves cannot fuse, resulting in a cleft palate. This observation eliminated the previous belief that the tongue may be an obstruction to the palatal fusion and established that a synergistic action of the complete facial musculature is needed for proper palatal fusion. Additional information from maxillofacial surgeons, suggesting that the cleft palate is a muscle disease rather than a consequence of
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